Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment

IF 2.2 4区医学 Q2 SUBSTANCE ABUSE

American Journal on Addictions Pub Date : 2026-06-16 Epub Date: 2026-02-25 DOI:10.1111/ajad.70151

Erin L. Winstanley PhD, Jane M. Liebschutz MD, MPH, Cristina Murray-Krezan PhD, Galen E. Switzer PhD, Samantha Nash BA, Sarah Kawasaki MD

{"title":"Brief report: Meth, tranq, gas station heroin & other drugs complicating addiction treatment","authors":"Erin L. Winstanley PhD, Jane M. Liebschutz MD, MPH, Cristina Murray-Krezan PhD, Galen E. Switzer PhD, Samantha Nash BA, Sarah Kawasaki MD","doi":"10.1111/ajad.70151","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Objectives</h3>\n \n <p>Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A national survey (<i>n</i> = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States. This study reports the results of a single survey item on clinicians' perceptions of other drugs, besides IMF, complicating treatment.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Clinicians reported methamphetamine (86.4%), synthetic cannabinoids (42.7%), and xylazine (41.4%) were complicating treatment; reports varied by geographic region.</p>\n </section>\n \n <section>\n \n <h3> Conclusions and Scientific Significance</h3>\n \n <p>Rapid clinician surveys can provide real-time data on changing patterns of drug use's impact treatment outcomes.</p>\n </section>\n </div>","PeriodicalId":7762,"journal":{"name":"American Journal on Addictions","volume":"35 4","pages":"543-546"},"PeriodicalIF":2.2000,"publicationDate":"2026-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12997185/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal on Addictions","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ajad.70151","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 0

Abstract

Background and Objectives

Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment.

Methods

A national survey (n = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States. This study reports the results of a single survey item on clinicians' perceptions of other drugs, besides IMF, complicating treatment.

Results

Clinicians reported methamphetamine (86.4%), synthetic cannabinoids (42.7%), and xylazine (41.4%) were complicating treatment; reports varied by geographic region.

Conclusions and Scientific Significance

Rapid clinician surveys can provide real-time data on changing patterns of drug use's impact treatment outcomes.

Abstract Image

查看原文本刊更多论文

简要报告：冰毒、安定剂、加油站海洛因和其他药物使成瘾治疗复杂化。

背景和目的：使用芬太尼的患者治疗效果较差；然而，人们对其他使治疗复杂化的药物知之甚少。方法：一项全国调查（n = 396）进行了随机抽样的临床医生放弃开丁丙诺啡在美国。本研究报告了一个关于临床医生对其他药物的看法的单一调查项目的结果，除了IMF，复杂的治疗。结果：临床医生报告甲基苯丙胺（86.4%）、合成大麻素（42.7%）和噻嗪（41.4%）是治疗的并发症；报告因地理区域而异。结论及科学意义：快速的临床医生调查可以提供药物使用模式变化对治疗结果影响的实时数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal on Addictions SUBSTANCE ABUSE-

CiteScore

5.00

自引率

0.00%

发文量

118

期刊介绍： The American Journal on Addictions is the official journal of the American Academy of Addiction Psychiatry. The Academy encourages research on the etiology, prevention, identification, and treatment of substance abuse; thus, the journal provides a forum for the dissemination of information in the extensive field of addiction. Each issue of this publication covers a wide variety of topics ranging from codependence to genetics, epidemiology to dual diagnostics, etiology to neuroscience, and much more. Features of the journal, all written by experts in the field, include special overview articles, clinical or basic research papers, clinical updates, and book reviews within the area of addictions.